Table 2.
Overview of collected variables.
| Collection period | Category | Variable | Unit(s) or categories | ||
| Collected before visit of late-effects clinic | Childhood cancer type and treatment | Primary childhood cancer diagnosis | ICCC-3a classification | ||
| Treatment protocol | Name and arm | ||||
| Chemotherapy, per regimen | TCDb | ||||
| Radiotherapy field | |||||
| Cranial/craniospinal | TCD, fractions (if applicable) | ||||
| Total body | TCD, fractions (if applicable) | ||||
| Abdominal | TCD, fractions (if applicable) | ||||
| Pancreas involvement | TCD, fractions (if applicable) | ||||
| Surgery procedure | |||||
| Autologous stem cell transplantation | Yes / No, conditioning regimen | ||||
| Allogeneic stem cell transplantation | Yes / No, conditioning regimen | ||||
| Relapse | Yes / No | ||||
| Patient characteristics | Sex | Male / Female | |||
| Date of birth | Date | ||||
| Date of childhood cancer diagnosis | Date | ||||
| Date of study measurements (follow-up date) | Date | ||||
| Medical history | Height at cancer diagnosis | Centimeter | |||
| Weight at cancer diagnosis | Kilogram | ||||
| Growth hormone deficiency | Yes / No | ||||
| Growth hormone replacement | Yes / No | ||||
| Hypothyroidism | Yes / No | ||||
| Hypogonadism | Yes / No | ||||
| Hypocortisolism with steroid replacement | Yes / No | ||||
| Collected at visit of late-effects clinic | Physical examination | Height | Centimeter | ||
| Weight | Kilogram | ||||
| Waist circumference | Centimeter | ||||
| Hip circumference | Centimeter | ||||
| Blood pressure | mmHg | ||||
| General health questionnaire | Does the survivor have or has the survivor experienced | ||||
| High cholesterol | Yes / No, age at diagnosis | ||||
| Hypertension | Yes / No, age at diagnosis | ||||
| Diabetes mellitus | Yes / No, age at diagnosis | ||||
| Myocardial infarction | Yes / No, age at diagnosis | ||||
| Stroke | Yes / No, age at diagnosis | ||||
| Medication use | Type, dose, age at start | ||||
| Smoking status | Yes / Former / No | ||||
| Cardiovascular disease in family | Relative, type of disease, age at diagnosis | ||||
| Questionnaire to Assess Health enhancing physical activity | N/Ac | N/A | |||
| Dual-energy x-ray absorptiometry scan | Total body fat | Percentage | |||
| Z-score total body fat | Z-score | ||||
| Lean body mass | Kilogram per m2 | ||||
| Appendicular lean body mass | Kilogram per m2 | ||||
| 6-minute walking test | N/A | Meter | |||
| Data determined from stored samples | Serum biomarkers | ||||
| High-density lipoprotein | mmol/L | ||||
| Low-density lipoprotein | mmol/L | ||||
| Total cholesterol | mmol/L | ||||
| Apolipoprotein-B | g/L | ||||
| Glucose | mmol/L | ||||
| Insulin | pmol/L | ||||
| Adiponectin | ug/mL | ||||
| Leptin | ng/mL | ||||
| Uric acid | mmol/L | ||||
| High sensitivity C-reactive protein | mg/L | ||||
| IL-6d | pg/mL | ||||
| hsTNFae | pg/mL | ||||
| IL-1f | pg/mL | ||||
| IGF-1g | ug/L | ||||
| Creatinine | mg/mmol | ||||
| Urea | mmol/L | ||||
| LHh | U/L | ||||
| FSHi | U/L | ||||
| AMHj | ug/L | ||||
| Estradiol | pmol/L | ||||
| Testosterone | nmol/L | ||||
| DNA from blood/saliva | N/A | ||||
aICCC-3: International Classification of Childhood Cancer, edition 3.
bTCD: total cumulative dose.
cN/A: not applicable.
dIL-6: interleukin-6.
ehsTNF: high-sensitivity tumor necrosis factor alpha.
fIL-1: interleukin-1.
gIGF-1: insulin-like growth factor 1.
hLH: luteinizing hormone.
iFSH: follicle stimulating hormone.
jAMH: anti-Müllerian hormone.